Published on
Dec 29, 2024
Nicotinamide trial for Alzheimer’s disease shows no clear benefit in reducing tau proteins
A recent study published in Neurology explored whether high doses of nicotinamide, a derivative of vitamin B3, could reduce a protein associated with Alzheimer’s disease progression. Despite promising results in animal models, the study found no …
Source:
PsyPost
-
Neutral
